However, many may not be aware that semaglutide has been available in oral form since it was approved by the FDA in 2019
From Treatment to Trend: The Expanding Reach of GLP-1RAs We are now witnessing the widening of indications and demand, including: Non-diabetic obesity Polycystic ovary syndrome (PCOS) Fatty liver disease Cardiovascular risk reduction Off-label use for wellness or cosmetic weight loss This broadening scope presents opportunities and risks
Semaneo 0.25mg Injection Combipack is used for cardiovascular risk reduction and weight management in adults with obesity or in adults with overweight who have at least one weight-related health condition
For tirzepatide specifically, common side effects include constipation , diarrhea , headaches , and body aches
And because the scale is moving in the right direction, many women assume everything internally is improving too
Human thyroid C-cells appear to express GLP-1 receptors at lower levels than rodent C-cells, suggesting that humans may be less susceptible to GLP-1-mediated thyroid proliferation, though evidence on receptor expression varies